Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
Humana Inc. (NYSE: HUM) and Mays Business School at Texas A&M University have announced the 2021 Humana-Mays Healthcare Analytics Case Competition, offering a total prize package of $80,000. First place will receive $50,000, second place $20,000, and third place $10,000. The competition is open to master’s students from accredited U.S. institutions, encouraging teams to solve a real-world healthcare business challenge. The event highlights Humana's commitment to analytics in healthcare and aims to advance student learning through real-world applications.
Humana Inc. (NYSE: HUM) will present at the Morgan Stanley Conference on September 15, 2021, at 8:45 a.m. Eastern. Bruce D. Broussard, the President and CEO, will lead the presentation. Interested investors can access a live audio webcast through humana.com. Participants are advised to log in 15 minutes early to ensure system compatibility. Humana is dedicated to advancing health care for its members through comprehensive services including in-home care and data analytics.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.70 per share, payable on October 29, 2021, to shareholders of record as of September 30, 2021. This move underscores Humana's commitment to providing benefits to its investors while enhancing integrated care solutions aimed at improving health outcomes and lowering costs for its members.
Humana continues to support healthcare professionals with resources and tools, ensuring easier navigation through healthcare services.
Humana Inc. (NYSE: HUM) has completed its acquisition of Kindred at Home (KAH), enhancing its position as the largest provider of home healthcare in the U.S. KAH serves over 550,000 patients annually, and its integration into Humana's Home Solutions business aims to improve patient outcomes and satisfaction. The transition to the new CenterWell brand is set for 2022. This acquisition is expected to accelerate clinical innovation and enhance overall healthcare delivery, while also expanding Humana’s workforce with thousands of new caregivers.
Humana Inc. (NYSE: HUM) has released its 2020 Corporate Social Responsibility (CSR) report, highlighting its dedication to health equity and community needs. Amid the COVID-19 pandemic, the company launched new employee benefits, conducted over 6.2 million health screenings, and contributed $50 million in aid to underserved communities. Humana also achieved Energy Star certification for 22 sites, showcased its commitment to health equity by appointing new leadership, and emphasized transparency in its environmental, social, and governance practices moving forward.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $3.0 billion in senior notes, consisting of three tranches: $1.5 billion due 2023, $750 million due 2027, and $750 million due 2032. The expected net proceeds are approximately $2.973 billion. These funds will primarily support the $5.7 billion acquisition of Kindred at Home. If the acquisition is not finalized by January 22, 2022, the company will redeem the 2023 notes. The press release includes cautionary forward-looking statements regarding potential risks affecting business performance.
Humana Inc (NYSE: HUM) has appointed Sue Schick as President of its Group, Military, and Specialty businesses, effective September 1, 2021. Schick, who joined Humana in 2020 and has over 30 years of industry experience, succeeds Chris Hunter, who leaves to pursue other opportunities. Humana aims for ambitious growth in these segments. Currently, the Group, Military, and Specialty business serves 1.2 million employer group members and 12 million Commercial and Medicare Specialty members, while also administering the TRICARE health program for six million U.S. military beneficiaries.
Humana Inc. (NYSE: HUM) has announced a public offering of $3.0 billion in senior notes, comprising $1.5 billion of 0.650% notes due 2023, $750 million of 1.350% notes due 2027, and $750 million of 2.150% notes due 2032. The net proceeds, approximately $2.973 billion, will be used for the acquisition of Kindred at Home, which amounts to about $5.7 billion, inclusive of $1.9 billion in debt assumption. The offerings are scheduled to close on August 3, 2021, and are not conditioned on the acquisition's completion.
Summary not available.
Humana reported its 2Q21 results, with GAAP revenue at $20.645 billion, a year-over-year increase from $19.083 billion in 2Q20. However, GAAP pretax income dropped significantly from $2.586 billion in 2Q20 to $738 million in 2Q21. The diluted EPS fell to $4.55 from $13.75, while the non-GAAP adjusted EPS was $6.89, down from $12.56. Despite challenges from the ongoing pandemic, the company revised its FY2021 GAAP EPS guidance to $24.97-$25.47 and maintained its adjusted EPS guidance of $21.25-$21.75. A substantial gain from the acquisition of Kindred at Home is expected, estimated at $1 billion.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
